A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patientsAlessandra Tedeschi, Davide Rossi, Marina Motta et al.|Haematologica|2015Cited by 25
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia studyFrancesco Autore, Luca Laurenti, Giulia Quaresmini et al.|Hematological Oncology|2023Cited by 2
POSTER: CLL-347 Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationFrancesca Perutelli, Marta Coscia, Elia Boccellato et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
CLL-347 Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationFrancesca Perutelli, Marta Coscia, Elia Boccellato et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantationFrancesca Perutelli, Marta Coscia, Elia Boccellato et al.|British Journal of Haematology|2025Cited by 0